可能這是牛津疫苗現狀? - 失敗了 to protect vaccinated monkeys from being infected by the virus,但對 pneumonia 和 lung disease 是有效的
www.thehindu.com
Being tested by researchers at Oxord University failed to protect vaccinated monkeys from being infected by the virus. However, the test animals appeared to be protected from pneumonia.
www.cbsnews.com
Scientists from Oxford University's Jenner Institute have defended its coronavirus vaccine in the wake of criticism in a Forbes article last week about its effectiveness in monkeys. The article compared Oxford's vaccine with a vaccine candidate from China-based Sinovac Biotech.
According to Oxford's team, safety trials in monkeys for both vaccines demonstrated "clear promise, with high efficacy in each case against lung disease, and research on both vaccines should continue as planned." The team said both vaccines "were able to provide clear protection against lower respiratory tract infection in the respective models."
Potential Oxford vaccine fails to prevent coronavirus spread in monkeys, but protects from pneumonia
This vaccine is among the eight that are ahead in terms of being tested in humans for efficacy
Being tested by researchers at Oxord University failed to protect vaccinated monkeys from being infected by the virus. However, the test animals appeared to be protected from pneumonia.

U.S. commits $1.2 billion to production of Oxford coronavirus vaccine
President Trump has launched Operation Warp Speed, which aims to make millions of doses of a coronavirus vaccine available by years end.

Scientists from Oxford University's Jenner Institute have defended its coronavirus vaccine in the wake of criticism in a Forbes article last week about its effectiveness in monkeys. The article compared Oxford's vaccine with a vaccine candidate from China-based Sinovac Biotech.
According to Oxford's team, safety trials in monkeys for both vaccines demonstrated "clear promise, with high efficacy in each case against lung disease, and research on both vaccines should continue as planned." The team said both vaccines "were able to provide clear protection against lower respiratory tract infection in the respective models."